Atlas FDA

Cardiovascular Review Station The IMPAX Cardiovascular suite is a cardiovascular information system, providing image arc

FDA device recall Z-1434-2011 · posted 2011-02-24 · Terminated

Recall details

Recalling firm
AGFA Corp.
Reason for recall
Echocardiography volume measurements performed within CRS were not reflected correctly in associated Results Management (RM) reports.
Action taken
The firm, AGFA Healthcare, sent a "Safety Notice" dated January 27, 2011 to all customers. The notice described the product, problem and action to be taken by firm and customer. AGFA informed the customers that a software upgrade was made between December 2008 and February 2010 and instructed the customers to distribute this information to all individuals within their facility and to complete and return the attached URGENT SAFETY NOTICE FEEDBACK FORM via fax to 864-421-1664 or email to debbie.norris@agfa.com. Note: Service Bulletin DD+DIS100.09E, was issued March 2009 and an upgrade from Software Versions 2.12.05 through 2.14.03.SU1 to Software Version CRS 2.14.03.SU2 was required for the impacted sites. Most identified consignees/customers required the software upgrade, but some consignees/customers had already been upgraded prior to the event and did not require additional upgrades. If you have any questions about this matter, please contact the Post Market/QARA North America via email at debbie.norris@agfa.com or call at 864-421-1754.
Root cause
Other
Status
Terminated
Product code
LLZ
Quantity affected
107
Distribution
Worldwide distribution: USA and country of: Canada
Date initiated
2011-01-27
Date posted
2011-02-24
Date terminated
2011-03-29
Location
Greenville, SC

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
AGFA HEARTLAB CARDIOVASCULAR (K050228)Heartlab, Inc.2005-02-18